VECOXAN®

Anticoccidial agent for the treatment of Coccidiosis in cattle, sheep and goats.

FOR ANIMAL USE ONLY

VECOXAN®

Oral Suspension

Reg. No. G1405 (Act 36/1947)

Namibia Reg. No. V95/17.4.1/395 [NS0]

TREATS COCCIDIOSIS IN CATTLE, SHEEP AND GOATS.

INDICATIONS

Anticoccidial agent for the treatment of coccidiosis in cattle, sheep and goats.

Vecoxan® is effective in cattle against Eimeria bovis and E. zuernii, and in sheep against E. parva, E. ovina, E. ovinoidalis, E. ahsata, E. arloingi, E. pallida, E. faurei and E. crandallis.

COMPOSITION

Diclazuril 2,5 mg/mℓ.

CAUTION

STORAGE INSTRUCTIONS

  • Store at or below 30 °C.
  • Do not use this veterinary medicinal product after the expiry date which is stated on the container label.

WARNINGS

  • Withdrawal period: Meat – Animals intended for human consumption MUST NOT be slaughtered during treatment and for 24 hours after last treatment.

      Milk – The milk from cattle or goats treated with Vecoxan® MUST NOT be used for human consumption.

  • Handle with care.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • If there is no recent and confirmed history of clinical coccidiosis, the presence of coccidiosis in the flock or herd should be established by means of faecal sampling prior to treatment.
  • In certain cases, only a transient decrease in oocyst shedding may be achieved in calves
  • Treat all exposed lambs in the flock, or calves in the herd.
  • Additional supportive therapy may be necessary to alter the course of an established clinical infection in individual animals already showing signs of diarrhoea.
  • As coccidiosis may be indicative of inadequate flock or herd hygiene, measures should be taken to improve hygiene.
  • Frequent and repeated use of antiprotozoal agents may lead to the development of resistance in the target parasite.
  • As with all oral remedies, it is advisable to ensure that animals have been immunised against pulpy kidney disease before drenching.
  • Avoid contact of the product with the eyes, skin and mouth.
  • Do not eat, drink or smoke whilst handling the product.
  • Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
  • Do not store unused containers for future use.
  • Do not contaminate rivers, dams or any water sources with containers or waste.
  • Wash hands thoroughly after use.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

SHAKE WELL BEFORE USE.

Vecoxan® is suitable for use in cattle, sheep and goats irrespective of age, sex, condition or stage of pregnancy and under all normal practices of management, nutrition and mating.

To ensure correct dosage, body weight should be determined as accurately as possible.

Recommended dose

1 mg Diclazuril per kg body weight as a single oral dose (This is equivalent to 1 mℓ Vecoxan®per 2,5 kg body weight.)

Cattle

Depending on the body weight of the animal, practical dosing is as follows:

Body weight (kg)Dose (m)Number of doses per pack
  1 2 2,5 5
502050100125250
60244183104208
7028357189178
8032316278156
9036275569138
10040255062125
11044224556113
12048204152104
1305219384896
1405617354489
1506016334183
etc.     

Sheep and Goats

Depending on the body weight of the animal, practical dosing is as follows:

Body weight (kg)Dose (m)Number of doses per pack
  1 2 2,5 5
525001 0001 2502 500
1042505006251 250
156166333416833
208125250312625
2510100200250500
301283166208416
351471142178357
etc.     

EFFICACY

Diclazuril is a benzene acetonitrile agent with anticoccidial action against Eimeria species. Depending on the species, diclazuril has coccidiocidal efficacy against the asexual or sexual stages of the parasite development cycle. Diclazuril treatment has only limited effect on the intestinal lesions caused by parasitic stages older than 16 weeks.

Treatment with diclazuril causes interruption of the coccidial life cycle and of oocyst secretion for approximately 2 weeks after administration. Treatment with Vecoxan® therefore bridges the period of decreased maternal immunity observed at approximately 4 weeks of age.

PRESENTATION

White suspension, in white high-density polyethylene (HDPE) drench flask, with tamper evident high-density polyethylene (HDPE) closure, nozzle closure and screw cap containing 200 mℓ, 1 ℓ, 2 ℓ, 2,5 ℓ, or 5 ℓ.

Not all pack sizes may necessarily be marketed.

REGISTRATION HOLDER                                         

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan,

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

8 June 2024